Literature DB >> 15468395

Efficacy of the pain pump catheter in immediate autologous breast reconstruction.

Michael Baroody1, Michael N Tameo, Richard W Dabb.   

Abstract

The purpose of the investigation was to evaluate the efficacy of a slow bupivacaine infusion at postoperative surgical sites in immediate breast reconstruction patients. This prospective study included 16 patients who underwent autologous breast reconstruction with a latissimus dorsi pedicled flap immediately after mastectomy. A two-site infusion kit with dual split-flow catheters was secured at the operative sites before skin closure. A spring-loaded disposable pump then infused 0.25% bupivacaine at a rate of 2.08 cc per catheter per hour for 48 continuous hours. Patient pain levels, nausea/emesis, and oral and intravenous narcotic use were then recorded at 12-hour intervals. Medication use was converted to pain units for results comparison (one pain unit was defined as the equivalent of 10 mg of intravenous morphine). A retrospective control group comprised 16 consecutive patients from December of 1999 to October of 2002 who underwent the same surgery by the same surgeon using oral and intravenous pain medications. The experimental group demonstrated a more than fivefold decrease in the use of oral and intravenous pain medications compared with the historical controls (6.7 versus 1.7 pain units) (p < 0.001). The overall pain experienced by the catheter patients was nearly twofold less than the pain experienced by those without the catheter (1.8 versus 3.4 on the visual analog pain scale) (p < 0.017). Twenty-eight percent of the experimental group experienced nausea/emesis compared with 61 percent in the control group. No complications occurred with the use of the pain pump catheter. A 48-hour infusion of 0.25% bupivacaine significantly decreases the need for postoperative narcotics and the over-all pain experience in immediate breast reconstruction patients. This effective form of pain control may alleviate patient concerns of postoperative pain and may safely downstage many plastic surgery procedures, such as immediate breast reconstruction, and many cosmetic procedures to same-day status when the primary indication for admission is pain management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468395     DOI: 10.1097/01.prs.0000133173.71201.3c

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Cost-effectiveness analysis of levobupivacaine 0.5 %, a local anesthetic, infusion in the surgical wound after modified radical mastectomy.

Authors:  Lourdes Ferreira Laso; Amanda López Picado; Fernando Antoñanzas Villar; Laura Lamata de la Orden; Mar Ceballos Garcia; Carolina Ibañez López; Lorena Pipaon Ruilope; Felix Lamata Hernandez; Cesar Valero Martinez; Felipe Aizpuru; Roberto Hernandez Chaves
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859

2.  A review of pain pumps in plastic surgery.

Authors:  Geethan J Chandran; Donald H Lalonde
Journal:  Can J Plast Surg       Date:  2010

3.  Impact of liposome bupivacaine on the adequacy of pain management and patient experiences following aesthetic surgery: Results from an observational study.

Authors:  Michael C Edwards; Evan Sorokin; Mark Brzezienski; Farzad R Nahai; Richard Scranton; Holly Wall; Simeon Wall; Stephan Finical; Kevin Smith
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

Review 4.  Avoiding Opioids and Their Harmful Side Effects in the Postoperative Patient: Exogenous Opioids, Endogenous Endorphins, Wellness, Mood, and Their Relation to Postoperative Pain.

Authors:  Bradley C Stephan; Fereydoun D Parsa
Journal:  Hawaii J Med Public Health       Date:  2016-03

Review 5.  Issues related to choice of breast reconstruction in early-stage breast cancer.

Authors:  Kristina O'Shaughnessy; Neil Fine
Journal:  Curr Treat Options Oncol       Date:  2006-03

6.  Study protocol for a double blind, randomised, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy: SUB-pectoral Local anaesthetic Infusion following MastEctomy (SUBLIME) study.

Authors:  R Langford; I Brown; J Vickery; K Mitchell; C Pritchard; S Creanor
Journal:  BMJ Open       Date:  2014-09-30       Impact factor: 2.692

7.  Ropivacaine continuous wound infusion after mastectomy with immediate autologous breast reconstruction: A retrospective observational study.

Authors:  Jeong Eun Lee; Young Je Park; Jeong Woo Lee
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.889

Review 8.  Perioperative Blocks for Decreasing Postoperative Narcotics in Breast Reconstruction.

Authors:  Ariel Clare Johnson; Salih Colakoglu; Angela Reddy; Clara Marie Kerwin; Roland A Flores; Matthew L Iorio; David W Mathes
Journal:  Anesth Pain Med       Date:  2020-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.